Genelux Corporation
GNLX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.00 | 0.77 | 0.14 | -0.05 |
| FCF Yield | -4.46% | -6.59% | -5.80% | -5.93% |
| EV / EBITDA | -19.05 | -14.23 | -10.41 | -7.72 |
| Quality | ||||
| ROIC | -40.53% | -30.43% | -24.71% | -34.64% |
| Gross Margin | 0.00% | 0.00% | 0.00% | -25.33% |
| Cash Conversion Ratio | 0.83 | 0.95 | 0.73 | 0.48 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -91.03% |
| Free Cash Flow Growth | 1.14% | -31.27% | -24.26% | 23.84% |
| Safety | ||||
| Net Debt / EBITDA | 0.37 | 0.66 | 1.88 | 0.77 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -3,796.99 | -4,330.36 | -1,109.07 |